Myron Z. Holubiak
Net Worth
Last updated:
What is Myron Z. Holubiak net worth?
The estimated net worth of Mr. Myron Z. Holubiak is at least $11,080,590 as of 27 Sep 2019. He owns shares worth $720,590 as insider and has received compensation worth at least $10,360,000 in Citius Pharmaceuticals, Inc..
What is the salary of Myron Z. Holubiak?
Mr. Myron Z. Holubiak salary is $1,480,000 per year as Pres, Chief Executive Officer & Director in Citius Pharmaceuticals, Inc..
How old is Myron Z. Holubiak?
Mr. Myron Z. Holubiak is 78 years old, born in 1947.
What stocks does Myron Z. Holubiak currently own?
As insider, Mr. Myron Z. Holubiak owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | Pres, Chief Executive Officer & Director | 558,597 | $1.29 | $720,590 |
What does Citius Pharmaceuticals, Inc. do?
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Myron Z. Holubiak insider trading
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals key executives
Citius Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Myron S. Czuczman M.D. (66) Executive Vice President & Chief Medical Officer
- Mr. Jaime Bartushak (57) Chief Financial Officer & Chief Accounting Officer
- Mr. Leonard L. Mazur (80) Executive Chairman & Sec.
- Mr. Myron Z. Holubiak (78) Pres, Chief Executive Officer & Director